Download PDF
1 / Pages

Other users also viewed these articles

Characterization of AmpC ß-lactamase mutations of extensively drug-resistant Pseudomonas aeruginosa isolates that develop resistance to ceftolozane/tazobactam during therapy Marta Fernández-Esgueva; Ana Isabel López-Calleja; Xavier Mulet; Pablo A. Fraile-Ribot; Gabriel Cabot; Rafael Huarte; Antonio Rezusta; Antonio Oliver;
Enferm Infecc Microbiol Clin. 2020;38:474-8
Ceftolozane/tazobactam for the treatment of Pseudomonas aeruginosa infections: A multicenter case series analysis Inês Leonor Leitão; Carla Mimoso Santos; Paulo André; Sara Lino; Marcos Lemos; Filipe Froes;
Enferm Infecc Microbiol Clin. 2023;41:454-61
Assessment of a semi-automated enrichment system (Uroquattro HB&L) for detection of faecal carriers of ESBL-/AmpC-producing Enterobacterales Patricia Pérez-Palacios; Lorena López-Cerero; Carmen Lupión; Alvaro Pascual;
Enferm Infecc Microbiol Clin. 2020;38:367-70